The trademark application Finadosin was filed by MIP Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 15, 2023, and it was registered by office on June 22, 2023 without any oppositions.
The application was filed in German (English was selected as the second language).